ERBB2 and breast carcinoma: In non-ErbB2-overexpressing breast cancer cell lines, loss of CHIP expression was shown to increase the expression of transcriptional co-regulator SRC-3, with increased expression of pro-oncogenic proteins such as Smad2 and twist, to promote metastasis [34].